MeSH term
Frequency | Condition_Probility | Amino Acid Sequence | 5 | 0.0 |
Animals | 13 | 0.0 |
Base Sequence | 4 | 0.0 |
Cell Division/physiology | 2 | 0.0 |
Cell Nucleus/metabolism | 3 | 0.0 |
Cells, Cultured | 5 | 0.0 |
Humans | 25 | 0.0 |
*Intercellular Signaling Peptides and Proteins | 11 | 2.0 |
Male | 8 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 12 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Transfection | 4 | 0.0 |
DNA/biosynthesis | 3 | 0.0 |
DNA Repair | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Gene Expression Profiling | 4 | 0.0 |
Oligonucleotide Array Sequence Analysis | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
Up-Regulation | 2 | 0.0 |
Cell Division | 5 | 0.0 |
*Nuclear Proteins | 2 | 0.0 |
Blotting, Western | 5 | 0.0 |
Cell Line | 2 | 0.0 |
Mice | 8 | 0.0 |
Protein p53/metabolism | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Adult | 3 | 0.0 |
Aged | 2 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Female | 6 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Middle Aged | 3 | 0.0 |
Immunohistochemistry | 4 | 0.0 |
Prognosis | 3 | 0.0 |
Prospective Studies | 2 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Nuclear Proteins/metabolism | 2 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Rats | 4 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
*Gene Expression Profiling | 2 | 0.0 |
Comparative Study | 5 | 0.0 |
Sensitivity and Specificity | 3 | 0.0 |
Carcinoma, Hepatocellular/*pathology | 2 | 4.0 |
Liver Neoplasms/*pathology | 2 | 3.0 |
